Example: biology
NAME OF THE MEDICINE - Medsafe
4 Table 2 – ®Efficacy of Daivobet® gel in adults compared to Daivonex Scalp Solution % of patients minimal 1 Statistically significantly less effective than Daivobet® gel (P<0.001) Safety A randomised, double-blind long-term clinical study including 869 patients with scalp psoriasis of at least moderate severity (according to the IGA) investigated the use of
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
New Brunswick Drug Plans Special Authorization Criteria ...
www2.gnb.ca• For the treatment of patients with severe, debilitating chronic plaque psoriasis who meet all of the following criteria: - Body surface area (BSA) involvement of >10% and/or significant involvement of the face, hands, feet or
Inflectra® (infliximab-dyyb) Injectable Medication ...
www.aetna.comGR-69299 (1-18) Inflectra ® (infliximab-dyyb) Injectable Medication Precertification Request . Page 3 of 4 (All fields must be completed and legible for Precertification Review.)
乾癬 - cosentyx.jp
www.cosentyx.jp外、内からの 影響をなるべく 減らしましょう。 3 4 乾癬の原因 乾癬の発症には免疫の異常が関係しています。 乾癬の原因はまだはっきりとわかっていませんが、
NEW ZEALAND DATA SHEET OH H O - Medsafe Home Page
www.medsafe.govt.nzPage 1of 8 NEW ZEALAND DATA SHEET Daivobet®50/500 ointment Calcipotriol 50 microgram/g Betamethasone 500 microgram/g present as dipropionate NAME OF …